Lipodystrophy syndrome in children infected with human immunodeficiency virus.
Lipodystrophy syndrome (LDS), a fat-wasting condition commonly reported in adults infected with human immunodeficiency virus (HIV), has been linked to the use of antiretroviral agents. Recently, LDS was observed in children infected with HIV Little is known about the pathophysiology of this condition, although it is believed that LDS has many causes and modes of presentation. Even less is known about what long-term effects LDS will have on HIV-infected patients. Three patients who developed LDS were observed in a pediatric HIV clinic. Due to the lack of knowledge about the condition's natural course and the benefits versus risks of treatment, they were not treated specifically for LDS. Their lipid profiles, however, continue to be monitored closely twice/year.
Wedekind
C A
CA
College of Pharmacy, University of Rhodes Island, Kingston, 02881, USA. wedekind@uri.edu
Pugatch
D
D
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008060:Lipodystrophy / Q000097:blood / Q000150:complications; D008297:Male; D013577:Syndrome; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D002784:Cholesterol